SATSUMA PHARMACEUTICALS INC

SATSUMA PHARMACEUTICALS INC

Share · US80405P1075 · STSA · A2PQPD (XNMS)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of SATSUMA PHARMACEUTICALS INC
Analyst Grade Summary
gauge-img
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
0
4
9
0
0
No Price
Share Float & Liquidity
Free Float 45,86 %
Shares Float 15,2 M
Shares Outstanding 33,15 M
Company Profile for SATSUMA PHARMACEUTICALS INC Share
Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. The company's lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in SUMMIT Phase 3 efficacy trials and can be self-administered with proprietary pre-filled, single-use, and nasal delivery device. Satsuma Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.

Company Data

Name SATSUMA PHARMACEUTICALS INC
Company Satsuma Pharmaceuticals, Inc.
Symbol STSA
Website https://www.satsumarx.com
Primary Exchange XNMS NASDAQ/NMS (GLOBAL MARKET)
WKN A2PQPD
ISIN US80405P1075
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO John A. Kollins MBA
Market Capitalization 36 Mio
Country United States of America
Currency USD
Employees 0,0 T
Address 400 Oyster Point Boulevard, 94080 South San Francisco
IPO Date 2019-09-13
Dividends from 'SATSUMA PHARMACEUTICALS INC'
Ex-Date Dividend per Share
28.03.2014 0,20 USD
11.02.2014 0,20 USD
01.11.2013 0,20 USD
02.08.2013 0,20 USD
26.06.2013 0,35 USD
02.05.2013 0,20 USD
19.12.2012 0,50 USD
02.11.2012 0,15 USD
02.08.2012 0,15 USD
26.09.2008 0,10 USD

Stock Splits

Date Split
19.11.2010 1:66

Ticker Symbols

Name Symbol
NASDAQ STSA
More Shares
Investors who hold SATSUMA PHARMACEUTICALS INC also have the following shares in their portfolio:
FURUKAWA CO
FURUKAWA CO Share
LONDON+QUADRANT H.T.10/40
LONDON+QUADRANT H.T.10/40 Bond